MustGrow Biologics Corp.
MGROF
$0.7884
-$0.0325-3.96%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -58.52% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -58.52% | -- | |||
| Cost of Revenue | 74.92% | 50.12% | |||
| Gross Profit | -118.95% | 431.53% | |||
| SG&A Expenses | -55.92% | 170.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.37% | 133.55% | |||
| Operating Income | 36.11% | -99.52% | |||
| Income Before Tax | 29.68% | -75.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 29.68% | -75.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 29.68% | -75.63% | |||
| EBIT | 36.11% | -99.52% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 29.71% | -75.74% | |||
| Normalized Basic EPS | 29.53% | -75.29% | |||
| EPS Diluted | 29.71% | -75.74% | |||
| Normalized Diluted EPS | 29.53% | -75.29% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||